Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-137099

Published: 2020

Journal Articles

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, MD, Didier Blaise, MD, Emanuele Angelucci, Luca Castagna, Jiri Pavlu, MDMRCP,FRCPath, Gerard Socie, MDPhD, Massimo Martino, Friedrich Stoelzel, PD, MD, Gesine Bug, Yves Chalandon, MD, Benedetto Bruno, MD, Victoria Potter, MBBS, BSc, FRACP, FRCPA, Eolia Brissot, MDPhD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-140657

Published: 2020

Journal Articles

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Joshua A Fein, MD, Roni Shouval, MD PhD, Myriam Labopin, MD, Fabio Ciceri, MD, Emanuele Angelucci, MD, Didier Blaise, MD, Johanna Tischer, William Arcese, MD PhD, Yener Koc, MD, Benedetto Bruno, MD, Jose L. Diez-Martin, MD PhD, Stella Santarone, MD, Simona Sica, MD PhD, Jurjen Versluis, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139519

Published: 2020

Journal Articles

Outcome of Two Loci Mismatched (≤6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study

Arnon Nagler, MD MSc, Myriam Labopin, MD, Benedetto Bruno, MD, Alessandro Rambaldi, MD, Pietro Pioltelli, MD, Giorgio La Nasa, MD, Gerard Socie, MD PhD, Stephan Mielke, MD, Marco Ruggeri, Riccardo Saccardi, MD, Uwe Platzbecker, MD, Jürgen Finke, MD, Annalisa Ruggeri, MD, Bipin N. Savani, MD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 4604.

https://doi.org/10.1182/blood-2019-122090

Published: 2019

Journal Articles

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Giuseppe Lia, PhD, Clara Di Vito, PhD, Marta Tapparo, PhD, Stefania Bruno, Elisa Zaghi, Michela Calvi, Lucia Brunello, Jacopo Mariotti, MD, Lorenzo Comba, Luisa Giaccone, Martina Fascì, Mario Boccadoro, Andrea Evangelista, MSc, Luca Castagna, MD, Giovanni Camussi, Domenico Mavilio, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 598.

https://doi.org/10.1182/blood-2019-126521

Published: 2019

Journal Articles

Treatment of Primary Plasma Cell Leukemia with Carfilzomib and Lenalidomide-Based Therapy: Results of the First Interim Analysis of the Phase 2 EMN12/HOVON129 Study

Blood (2019) 134 (Supplement_1): 693.

https://doi.org/10.1182/blood-2019-125120

Published: 2019

Journal Articles

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Luciano J. Costa, MD PhD, Simona Iacobelli, Marcelo C. Pasquini, MD, Riddhi Modi, PhD, Luisa Giaccone, Joan Bladé, MD PhD, Stefan Schonland, Andrea Evangelista, Jose A. Perez-Simon, MD PhD, Parameswaran Hari, MBBS, MD, Elizabeth E. Brown, PhD MPH, Sergio A Giralt, MD, Francesca Patriarca, Edward A. Stadtmauer, MD FACP, Laura Rosinol, MD PhD, Amrita Y. Krishnan, MD, Goesta Gahrton, MD PhD, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 259.

https://doi.org/10.1182/blood-2019-121367

Published: 2019

Journal Articles

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study

Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Emanuele Angelucci, MD, Fabio Ciceri, MD, José Luis Díez-Martín, MD PhD, Benedetto Bruno, MD, Simona Sica, MD, Yener Koc, MD, Zafer Gulbas, MD, Christoph Schmid, MD, Didier Blaise, MD PhD, Angelo Michele Carella, Giuseppe Visani, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 4584.

https://doi.org/10.1182/blood-2019-122279

Published: 2019

Journal Articles

Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor?

Camillo Almici, MD, Francesca Fontana, Giovanna Piovani, Piera Balzarini, Arabella Neva, Benedetto Bruno, MD, Cristina Skert, GianLuca Rotta, Simona Fisogni, MD, Rosanna Verardi, Andrea Bianchetti, Simona Braga, Michele Malagola, MD, Nicolò Manaresi, PhD, Fabio Facchetti, Mirella Marini, MD, Domenico Russo, MD

Blood (2019) 134 (Supplement_1): 4885.

https://doi.org/10.1182/blood-2019-121879

Published: 2019

Journal Articles

Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia

Jonathan Canaani, MD, Myriam Labopin, MD, Xiao Jun Huang, William Arcese, MD, Fabio Ciceri, MD, Didier Blaise, MD PhD, Giuseppe Irrera, Lucia Lopez Corral, Benedetto Bruno, MD PhD, Stella Santarone, MD, Maria Teresa van Lint, Antonin Vitek, MDPhD, Jordi Esteve, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 4584.

https://doi.org/10.1182/blood.V130.Suppl_1.4584.4584

Published: 2017

Journal Articles

Survival after Relapse Following Tandem Allogeneic Vs. Tandem Autologous Hematopoietic Cell Transplantation (HCT) for Myeloma (MM)

Myo Htut, MD, Anita D'Souza, MBBS, MD, Benedetto Bruno, MD PhD, Mei-Jie Zhang, PhD, Mingwei Fei, MS, Cristina Gasparetto, MD, Yago Nieto, MD PhD, Amrita Krishnan, MD, Parmeswaran Hari, MD MRCP, MS

Blood (2016) 128 (22): 833.

https://doi.org/10.1182/blood.V128.22.833.833

Published: 2016

Journal Articles

Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis

Annalisa Ruggeri, MD, Myriam Labopin, MD, Andrea Bacigalupo, MD, Zafer Gülbas, MD, Yener Koc, MD, Didier Blaise, MD PhD, Benedetto Bruno, MD PhD, Giuseppe Irrera, MD, Johanna Tischer, Jean diez Martin, Luca Castagna, MD, Fabio Ciceri, MD, Mohamad Mohty, MD PhD, Arnon Nagler

Blood (2016) 128 (22): 1165.

https://doi.org/10.1182/blood.V128.22.1165.1165

Published: 2016

Journal Articles

A Comparative Study of Biosimilar Filgrastim Versus Originator G-CSF for CD34+ Cells Mobilization and Autografting in Hematological Malignancies

Lucia Brunello, Luisa Giaccone, Maria Josè Fornaro, Matilde Scaldaferri, Valter Redoglia, Paola Omedè, PhD, Moreno Festuccia, Giovannino Ciccone, Massimo Massaia, MD, Dario Ferrero, Federica Cavallo, Antonio Palumbo, MD, Francesco Cattel, Andrea Evangelista, Mario Boccadoro, MD, Benedetto Bruno, MD PhD

Blood (2016) 128 (22): 2183.

https://doi.org/10.1182/blood.V128.22.2183.2183

Published: 2016

Journal Articles

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Blood (2016) 128 (22): 53.

https://doi.org/10.1182/blood.V128.22.53.53

Published: 2016

Journal Articles

Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Mohamad Mohty, MD PhD, Myriam Labopin, MD, Andrea Velardi, MD, Maria Teresa van Lint, MD, Donald Bunjes, Benedetto Bruno, MD PhD, Stella Santarone, MD, Johanna Tischer, Yener Koc, MD, Depei Wu, MDPhD, Zafer Gulbas, MD, Annalisa Ruggeri, MD, Florent Malard, MD PhD, Simona Piemontese, MD, Maria Teresa Lupo Stanghellini, MD, Chiara Bonini, MD, Claudio Bordignon, MD, Fabio Ciceri, MD, Arnon Nagler

Blood (2016) 128 (22): 672.

https://doi.org/10.1182/blood.V128.22.672.672

Published: 2016

Journal Articles

Allogeneic Stem Cell Transplantation Versus B-Cell-Receptor Inhibitors in 17p Deletion and/or Refractory Chronic Lymphocytic Leukemia: A Retrospective Comparative Analysis of 'Real Life' Approaches to High Risk Patients, on Behalf of Rete Ematologica Lombarda (REL) and Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Lucia Farina, MD PhD, Francesca Patriarca, Maddalena Mazzucchelli, Chiara Salvetti, MD, Giulia Quaresmini, Marta Medeot, MD, Daniele Vincenti, Gianluigi Reda, MD, Andrea Ferrario, MD, Francesco Zallio, MD, Anna Dodero, Benedetto Bruno, MD PhD, Paolo Corradini, Marco Montillo, MD

Blood (2016) 128 (22): 4695.

https://doi.org/10.1182/blood.V128.22.4695.4695

Published: 2016

Journal Articles

Prolonged Follow-up Confirmed a Role for Upfront Tandem Auto-Allo Transplant in Multiple Myeloma Also in the Era of New Drugs

Luisa Giaccone, Andrea Evangelista, Francesca Patriarca, Roberto Sorasio, MD, Massimo Pini, MD, Fabrizio Carnevale Schianca, MD, Moreno Festuccia, Lucia Brunello, Francesco Zallio, MD, Enrico Maffini, Paola Omedè, PhD, Sara Bringhen, MD, Nicola Mordini, MD, Renato Fanin, MD, Massimo Massaia, MD, Antonio Palumbo, MD, Giovannino Ciccone, MDPhD, Mario Boccadoro, MD, Benedetto Bruno, MD PhD

Blood (2016) 128 (22): 3469.

https://doi.org/10.1182/blood.V128.22.3469.3469

Published: 2016

Journal Articles

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Luca Castagna, MD, Alberto Mussetti, MD, Raynier Devillier, MD PhD, Alida Dominietto, MD, Magda Marcatti, MD, Giuseppe Milone, MD, Francesco Maura, MD, Benedetto Bruno, MD PhD, Sabine Furst, MD, Didier Blaise, MD PhD, Paolo Corradini, MD, Vittorio Montefusco, MD

Blood (2016) 128 (22): 3475.

https://doi.org/10.1182/blood.V128.22.3475.3475

Published: 2016

Journal Articles

Hematopoietic Cell Transplantation Comorbidity Index As Prognostic Variable in Patients with Invasive Fungal Infections

Alessandro Busca, MD, Roberto Passera, PharmD, PhD, Enrico Maffini, MD, Lucia Brunello, MD, Chiara Maria Dellacasa, MD, Semra Aydin, MD PhD, Chiara Frairia, MD, Sara Manetta, MD, Sara Butera, MD, Giorgia Iovino, MD, Luisa Giaccone, MD PhD, Mario Boccadoro, MD, Umberto Vitolo, Benedetto Bruno, MD PhD

Blood (2015) 126 (23): 5526.

https://doi.org/10.1182/blood.V126.23.5526.5526

Published: 2015

NARROW

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Outcome of Two Loci Mismatched (≤6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Treatment of Primary Plasma Cell Leukemia with Carfilzomib and Lenalidomide-Based Therapy: Results of the First Interim Analysis of the Phase 2 EMN12/HOVON129 Study

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study

Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor?

Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia

Survival after Relapse Following Tandem Allogeneic Vs. Tandem Autologous Hematopoietic Cell Transplantation (HCT) for Myeloma (MM)

Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis

A Comparative Study of Biosimilar Filgrastim Versus Originator G-CSF for CD34+ Cells Mobilization and Autografting in Hematological Malignancies

Extracellular Vesicles as Potential Biomarker for Acute Graft-Versus-Host-Disease

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Prolonged Follow-up Confirmed a Role for Upfront Tandem Auto-Allo Transplant in Multiple Myeloma Also in the Era of New Drugs

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Hematopoietic Cell Transplantation Comorbidity Index As Prognostic Variable in Patients with Invasive Fungal Infections

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only